Description

Insulin Degludec Injection (Huiyouda) is a recombinant long-acting human insulin analog formulated for extended glucose-lowering activity. Supplied in a 3ml pen cartridge containing 300 International Units (IU), this product is suitable for preclinical and in vitro studies in the field of endocrinology, diabetes mellitus, insulin resistance, and pharmacokinetics.

Manufactured by Huisheng Biopharmaceutical Co., Ltd., this insulin preparation mimics basal insulin release, maintaining glucose homeostasis over extended periods. It is structurally designed to self-associate into multi-hexamers, allowing slow and continuous insulin release in experimental models.

?? Research Use Only – Not intended for clinical or veterinary application.

Product Parameters

Applications in Research

Insulin Degludec is widely used in experimental models to study:

• Long-acting insulin pharmacokinetics

• Glycemic control in diabetic rodents

• Continuous basal insulin action

• Insulin analog comparison studies

• Insulin receptor activity in vitro

Its ultra-long action (up to 42 hours) offers a controlled platform for studying basal insulin profiles and dose-adjustment behaviors in simulated metabolic conditions.

Safety & Handling

• For research use only.

• Not for human or veterinary administration.

• Use in controlled laboratory environments.

• Follow institutional safety and disposal protocols.

Disclaimer

This product is intended strictly for research and laboratory purposes only. Not for human or animal therapeutic use. Ensure proper handling in accordance with institutional and regulatory guidelines.